Get started
Author

Nik Krajnc

Observed name: Krajnc, Nik
ORCID: 0000-0002-4146-5870
Observed ORCID: 0000-0002-4146-5870
OpenAlex ID: A5059613674
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
2023 · Nik Krajnc, Bianca Itariu, et al. · The Journal of Headache and Pain · 83
PDF
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
2022 · Nik Krajnc, Gabriel Bsteh, et al. · Neurotherapeutics · 74
PDF
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis
2023 · Gabriel Bsteh, Harald Hegen, et al. · Neurology · 58
PDF
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis
2023 · Annika Hofmann, Nik Krajnc, et al. · Acta Neuropathologica · 39
PDF
Long‐term outcome after COVID ‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study
2022 · Gabriel Bsteh, Hamid Assar, et al. · European Journal of Neurology · 29
Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes
2023 · Gabriel Bsteh, Stefan Macher, et al. · Headache The Journal of Head and Face Pain · 24
PDF
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis
2023 · Gabriel Bsteh, Harald Hegen, et al. · European Journal of Neurology · 23
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review
2021 · Nik Krajnc, Gabriel Bsteh, et al. · Frontiers in Neurology · 23
PDF
The Vienna idiopathic intracranial hypertension database—An Austrian registry
2023 · Philip Pruckner, Christoph Mitsch, et al. · Wiener klinische Wochenschrift · 22
PDF
Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis
2023 · Nik Krajnc, Victor Schmidbauer, et al. · Multiple Sclerosis Journal · 21
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
2022 · Gabriel Bsteh, Harald Hegen, et al. · European Journal of Neurology · 20
PDF
MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome
2023 · Gabriel Bsteh, Wolfgang Marik, et al. · The Journal of Headache and Pain · 19
PDF
Biomarkers of Progression Independent of Relapse Activity—Can We Actually Measure It Yet?
2025 · Gabriel Bsteh, Assunta Dal-Bianco, et al. · International Journal of Molecular Sciences · 16
PDF
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity
2024 · Gabriel Bsteh, Marie L. Aicher, et al. · Neurology · 15
Impact of vaccination on COVID ‐19 outcome in multiple sclerosis
2022 · Gabriel Bsteh, Christiane Gradl, et al. · European Journal of Neurology · 15
PDF
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis
2022 · Klaus Berek, Harald Hegen, et al. · Multiple Sclerosis Journal · 15
Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 infection: A systematic diagnostic approach
2023 · Birgit Ludwig, Matthias Deckert, et al. · European Journal of Neurology · 14
PDF
Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options
2021 · Nik Krajnc, Thomas Berger, et al. · Biomolecules · 13
PDF
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
2022 · Gabriel Bsteh, Nik Krajnc, et al. · Neurology · 12
PDF
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?
2024 · Gabriel Bsteh, Nik Krajnc, et al. · European Journal of Neurology · 11
PDF
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis—Evidence for applying a rebaselining concept
2024 · Gabriel Bsteh, Harald Hegen, et al. · Multiple Sclerosis Journal · 11
The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI – an external validation study
2024 · Stefan Macher, Wolfgang Marik, et al. · The Journal of Headache and Pain · 11
Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis
2022 · Nik Krajnc, Assunta Dal-Bianco, et al. · Multiple Sclerosis Journal · 11
The Vienna Idiopathic Intracranial Hypertension (VIIH) database – an Austrian registry
2022 · Philip Pruckner, Christoph Mitsch, et al. · Research Square · 11
PDF
Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis
2024 · Nik Krajnc, Leo Hofer, et al. · European Journal of Neurology · 10
PDF
Works count: 127
Citation count: 820
H-index: 15
I10-index: 28
Year
Topic
Type